Generate a tailored SOP for Dr. David Fiellin. Improve your application with a focused, well-structured draft.
David Fiellin is a Professor at Yale School of Medicine, specializing in Internal Medicine, Emergency Medicine, and Public Health. His work primarily focuses on the interface of primary care and addiction medicine, where he is the inaugural Director of the Yale Program in Addiction Medicine. He conducts research on the implementation of treatments for opioid use disorder and alcohol use disorder in specialized settings such as office-based and primary care environments, as well as emergency departments. As a Board Certified Addiction Medicine physician, his contributions include serving as Principal Investigator in multiple NIH-funded clinical trials and observational studies. Fiellin has received several accolades including awards from the American Association for Treatment of Opioid Dependence and the American Society of Addiction Medicine, and has been instrumental in editorial roles in various addiction-related journals. His commitment to compassionate patient care and academic excellence drives his diverse research interests in addiction medicine, public health, and health policy.
Yale School of Medicine • New Haven, CT
Professor of Medicine, focusing on addiction medicine and general health care.
Yale School of Medicine • New Haven, CT
Vice Chief for Faculty Affairs in the Department of General Internal Medicine.
Yale Program in Addiction Medicine • New Haven, CT
Director of the Yale Program in Addiction Medicine, emphasizing research and clinical practice.
GRE is optional for PhD applicants. TOEFL speaking scores below 26 or IELTS speaking below 7.5 may require summer English training.